Detalhe da pesquisa
1.
Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
Circulation
; 140(14): 1156-1169, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31510787
2.
Risk of target lesion failure in relationship to vessel angiographic geometry and stent conformability using the second generation of drug-eluting stents.
Am Heart J
; 162(6): 1069-1079.e2, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22137081
3.
Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement.
Nephrol Dial Transplant
; 24(7): 2175-9, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19211648
4.
Pitfalls and key lessons with the symmetry proximal anastomotic device in coronary artery bypass surgery.
Ann Thorac Surg
; 75(5): 1434-6, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12735558
5.
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials.
EuroIntervention
; 9(6): 709-20, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23628499
6.
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study.
EuroIntervention
; 8(2): 214-24, 2012 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22030265
7.
Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial.
JACC Cardiovasc Interv
; 5(6): 656-65, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22721662
8.
3-Dimensional optical coherence tomography assessment of jailed side branches by bioresorbable vascular scaffolds: a proposal for classification.
JACC Cardiovasc Interv
; 3(8): 836-44, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20723856
9.
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents.
JACC Cardiovasc Interv
; 3(11): 1190-8, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21087756